ArticleCytoJournal2025
Synchronous primary cancers involving the endometrium and fallopian tube: A case report.
Article in CytoJournal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The co-occurrence of uterine and adnexal malignancies poses significant diagnostic challenges in distinguishing synchronous primary tumors from metastatic lesions. This study presents a rare case of concurrent dedifferentiated endometrial carcinoma (DEC) and high-grade serous tubal carcinoma and highlights the critical role of integrated pathological and molecular analyses. A 58-year-old woman presented with a 2-month history of irregular vaginal bleeding. Transvaginal ultrasound demonstrated endometrial thickening (1 cm) with intrauterine fluid accumulation. Hysteroscopic biopsy confirmed endometrioid adenocarcinoma. The patient underwent laparoscopic radical hysterectomy with bilateral adnexectomy and pelvic lymphadenectomy. Histopathological examination identified two distinct neoplasms: (1) DEC (microsatellite instability-high subtype) located at the left uterine fundus and (2) High-grade serous carcinoma (SET subtype: solid, endometrioid-like, transitional patterns) in the right fallopian tube. Following surgery, six cycles of adjuvant chemotherapy with TP regimen (liposomal paclitaxel plus carboplatin) were administered. The patient remains disease-free at a 46-month follow-up. This case underscores the diagnostic complexity of synchronous gynecological malignancies. Comprehensive immunohistochemistry combined with molecular characterization is essential for accurate tumor classification, which directly determines staging precision and therapeutic decision-making. The favorable long-term outcome in this case suggests potential clinical implications for dual primary management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.